钙依赖性钙蛋白酶激活黏着斑激酶参与慢性淋巴细胞白血病细胞的侵袭性
本研究探讨B细胞受体(BCR)刺激后钙蛋白酶介导的黏着斑激酶(FAK)切割与活化在慢性淋巴细胞白血病(CLL)中的作用。BCR刺激后能释放Ca++的患者细胞全长FAK减少、Y397磷酸化切割型FAK增多,以IGHV未突变预后不良患者为主,且cortactin和HS1过表达;FAK抑制剂Defactinib可诱导CLL细胞凋亡。
要点
- BCR刺激后钙蛋白酶活性导致CLL细胞FAK切割,全长FAK减少。
- 能释放Ca++者Y397磷酸化切割型FAK增多,多见于IGHV未突变预后不良患者。
- Defactinib可诱导CLL细胞凋亡,FAK通路或为可成药致病途径。
核心结论
- 预后不良患者中cortactin和HS1过表达与FAK共同构成CLL可能可成药的致病通路。
研究设计与样本
- 本研究为体外实验,检测CLL细胞在BCR刺激后FAK、钙蛋白酶、cortactin和HS1的变化及FAK抑制剂Defactinib的凋亡效应。
主要发现
- BCR刺激后观察到全长FAK下调,与钙蛋白酶活性导致的FAK切割相关。
- BCR刺激后能释放Ca++的患者细胞全长FAK较少,Y397磷酸化切割/活化型FAK较多,这些特征多见于IGHV未突变预后不良患者。
- 上述细胞中cortactin和HS1蛋白过表达,提示可能与FAK相互作用。
- FAK抑制剂Defactinib处理可诱导CLL细胞凋亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Signalling events downstream the B-cell receptor (BCR) are central for the survival and progression of chronic lymphocytic leukaemia (CLL) cells. Focal adhesion kinase (FAK), regulated through calpain, interacts with molecules of BCR signalling, cytoskeletal modelling and disease progression, such as Src/Lyn, cortactin and HS1. Hypothesizing that FAK might play a key role in CLL pathogenesis, we observed a down-modulation of FAK whole form, associated with FAK cleavage due to calpain activity upon BCR stimulation. Patients, whose cells were able to release Ca++ after BCR stimulation, had less amount of full-length FAK, which translated into a higher presence of cleaved/activated form of the protein phosphorylated at Y397, these features being mostly shown by immunoglobulin heavy chain (IGHV)-unmutated poor-prognosis patients. Moreover, we found that cortactin and HS1 proteins were overexpressed in those cells, suggesting a possible interplay with FAK. Treatment with the FAK inhibitor Defactinib was able to induce apoptosis in CLL cells. In conclusion, the malignant phenotype in unfavourable-prognosis patients seems to be encouraged by the overexpression of cortactin and HS1, that, together with FAK, may be involved in a druggable pathogenetic pathway in CLL.
引用
- Severin F, Mouawad N, Ruggeri E, et al. Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness. Br J Haematol. 2023. PMID: 37495265. doi:10.1111/bjh.18996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。